Aspects of the present application relate to pharmaceutical formulations comprising imatinib or its salts, isomers, racemates, enantiomers, hydrates, solvates, metabolites, and polymorphs, and mixtures thereof. Further aspects relate to processes for preparing pharmaceutical formulations comprising imatinib or its salts, together with at least one pharmaceutically acceptable excipient.Linvention concerne, dans certains aspects, des formulations pharmaceutiques comprenant limatinib ou ses sels, isomères, racémates, énantiomères, hydrates, solvates, métabolites, polymorphes, et leurs mélanges. Dautres aspects concernent des procédés de préparation de formulations pharmaceutiques comprenant limatinib ou ses sels, ainsi quau moins un excipient pharmaceutiquement acceptable.
